CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFα, improves health-related quality of life in patients with moderate to severe Crohn’s disease
Author
B Feagan
BG Feagan
+39Â more
BG Feagan
BG Gazzard
Brian Feagan
C Canavan
DA Drossman
DA Drossman
Dorothy L. Keininger
E Keystone
EH Choy
EJ Balkom Schoon van
EJ Irvine
EJ Irvine
F Baert
F Blondel-Kucharski
F Casellas
GH Guyatt
GH Guyatt
GR Greenberg
GR Lichtenstein
JW Garrett
Liz O’Neil
P Rutgeerts
Paul Rutgeerts
PJ Rutgeerts
RD Cohen
Richard N. Fedorak
S Ghosh
S Schreiber
S Schreiber
S Schreiber
S Schreiber
S Schreiber
SB Hanauer
SJ Deventer van
Stefan Schreiber
T Bernklev
WJ Sandborn
WJ Sandborn
WR Best
Publication venue
Springer-Verlag
Publication date
01/01/2007
Field of study
Get PDF
Crossref
Springer - Publisher Connector
PubMed Central
Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease
Author
Russel MGVM
Schoon EJ
+6Â more
Stockbrugger RW
Van Balkom BPJ
Van Deventer SJH
Van Dullemen HM
Van Hogezand RA
Wolters FL
Publication venue
Publication date
01/06/2002
Field of study
No full text
ARTS repository - University of Groningen